`Tel: 571-272-7822
`
`Paper 110
`Entered: August 4, 2020
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and VALEANT
`PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner.
`
`IPR2017-001901
`Patent 7,214,506 B2
`
`Before ERICA A. FRANKLIN, SUSAN L. C. MITCHELL, and
`ROBERT A. POLLOCK, Administrative Patent Judges.
`
`MITCHELL, Administrative Patent Judge.
`
`ORDER
`Conduct of the Proceeding
`
`37 C.F.R. § 42.5(c)(2)
`
`1 IPR2017-01429 has been joined with the instant proceeding.
`
`
`
`IPR2017-00190
`Patent 7,214,506 B2
`
`Petitioner Argentum Pharmaceuticals (“Argentum”) requests
`
`authorization to file a Sur-Reply to the Reply by Kaken Pharmaceutical Co.,
`
`Ltd. and Valeant Pharmaceuticals International, Inc. (“Patent Owner”) in
`
`support of its joint motion with Petitioner Acrux DDS PTY Ltd. and Acrux
`Limited (“Acrux”) to terminate this proceeding. See Ex. 3003, 1.
`
`Specifically, Argentum asserts that good cause exists for its extension
`
`because it seeks to respond to Patent Owner’s statements concerning
`
`Argentum’s role and actions in this proceeding by providing the panel
`
`complete information. Id. Argentum requests one week to file its
`
`Sur-Reply. Id.
`
`Because we determine that the panel will benefit from the additional
`
`briefing concerning Argentum’s role and actions in this proceeding, we grant
`
`Argentum’s request. 37 C.F.R. § 42.5(a).
`
`Accordingly, it is
`
` ORDER
`
`ORDERED that the Argentum’s request to file a Sur-Reply to the
`
`Joint Motion to Terminate (Paper 105) is granted;
`
`FURTHER ORDERED that Argentum shall file its Sur-Reply on or
`
`before Tuesday, August 11, 2020;
`
`FURTHER ORDERED that Argentum’s Sur-Reply shall be no more
`
`than three pages.
`
`2
`
`
`
`IPR2017-00190
`Patent 7,214,506 B2
`
`PETITIONER:
`
`Tara Raghavan
`Steven J. Birkos
`RAKOCZY MOLINO MAZZOCHI SIWIK
`traghavan@rmmslegal.com
`sbirkos@rmmslegal.com
`
`PATENT OWNER:
`
`John Livingstone
`Naoki Yoshida
`Anthony Hartmann
`Barbara R. Rudolph
`Trenton Ward
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`john.livingstone@finnegan.com
`naoki.yoshida@finnegan.com
`hartmana@finnegan.com
`Barbara.rudolph@finnegan.com
`Trenton.ward@finnegan.com
`
`Toan P. Vo
`VALEANT PHARMACEUTICALS NORTH AMERICA LLC
`Toan.vo@bausch.com
`
`3
`
`